We offer two types of GLP-1 medication, Semaglutide and Tirzepatide. Both Semaglutide and Tirzepatide are administered through a once-weekly subcutaneous injection using a tiny insulin syringe. For those who have a fear of needles, we also offer a once daily oral tablet option of Semaglutide.

Our most popular product is Compounded Semaglutide injections, available for as little as $166 per month when purchased as a 3 month starter program ($498 total for 3 months), or $249 per month when purchased month to month.
Our Compounded Tirzepatide injections are available for as little as $266 per month when purchased as a 3 month starter program ($798 total for 3 months), or $399 per month when purchased month to month.
Our Compounded Semaglutide tablets are $324 a month for 30 pills, and are available to purchase month to month.
We also offer brand name medications, with our month to month Wegovy® priced at $1,839 per month, and our month to month Zepbound® priced at $1,498 per month.
All strengths for each medication are priced the same, with no hidden costs or membership fees.

Yes, you can purchase multiple vials at a time. Our injectable compounded semaglutide and compounded tirzepatide medications can be ordered on a month to month basis, or in a 3 month starter program for those new to GLP-1 medications or for those that want to start with OrderlyMeds on a starter dose. Our 3 month starter programs offer a buy two month, get the third month free discount.
Our Semaglutide starter program comes with one vial, with 4 doses each of .25mg, .5mg, and 1mg to get you started on your weight loss journey. It is priced at $498 total for 3 months ($166 per month).
Our Tirzepatide starter program comes with one vial, with 4 doses each of 2.5mg, 5mg, and 7.5mg to get you started on your weight loss journey. It is priced at $798 total for 3 months ($266 per month).

GLP-1 medications are mainly used to treat type 2 diabetes and, more recently, obesity. They mimic a hormone called GLP-1, which helps regulate blood sugar and appetite. These drugs boost insulin production when blood sugar is high, lower glucagon (which raises blood sugar), and slow digestion to help you feel full, reducing appetite.
We offer compounded Semaglutide and Tirzepatide, both given as a once-weekly injection with a tiny insulin syringe. For those who have a fear of needles, we also offer a once daily oral tablet option of Semaglutide.

Drug compounding involves mixing or altering ingredients to create medications tailored to individual patient needs. The FDA allows compounding pharmacies to fulfill medications that are in shortage, which includes our GLP-1 weight loss medications.1
With OrderlyMeds, you can trust that our GLP-1 medication is made from its base form, not the salt form. Our compounding pharmacies adhere to USP standards and federal guidelines, and we thoroughly vet each pharmacy for accreditations, licenses, and manufacturing processes.

A drug may be compounded for a patient who cannot be treated with an FDA-approved medication, such as a patient who has an allergy to a certain dye and needs a medication to be made without it, or an elderly patient or a child who cannot swallow a tablet or capsule and needs a medicine in a liquid dosage form. Practitioners in hospitals, clinics, and other health care facilities sometimes provide compounded drugs to patients when an FDA-approved drug is not medically appropriate to treat them. In these situations, compounding can serve an important patient need.²

Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed. However, Federal law addresses compounding by a licensed pharmacist in a state-licensed pharmacy, including provisions regarding insanitary conditions.²

We currently partner with seven different 503A designated pharmacy providers to compound the medications we provide our customers: RedRock, Hallandale, Anazao, The Pharmacy Hub, Southend, Nationwide, and Strive.
These traditional compounding pharmacies create customized medications tailored to individual prescriptions and are regulated by state boards and the FDA. They must adhere to USP standards, and are also subject to specific sections of the Federal Food, Drug and Cosmetic Act (FDCA), including requirements for compounding drugs based on valid patient-specific prescriptions. The FDA also inspects these pharmacies to ensure they meet safety standards and do not compound under insanitary conditions.³

We offer compounded versions of Semaglutide (the active ingredient in Wegovy® and Ozempic®) and Tirzepatide (the active ingredient in Zepbound® and Mounjaro®), tailored to your specific dosing needs. Our medications come in glass vials with syringes and alcohol prep pads, reducing waste and cost compared to the $1,100-$1,600 price tag of Big Pharma brands when insurance doesn’t cover them. Compounded meds are a great, affordable option, especially if your insurance doesn’t cover weight loss medications or if you need a specific dose during shortages.

We compound Semaglutide and Tirzepatide using pure active ingredients, sterile water, and inactive alcohol to maintain potency. Our partner pharmacies include Hallandale, RedRock, Southend, and AnazoaHealth. AnazoaHealth compounds with L-carnitine, and Southend compounds with vitamin B6.

Weight loss results with GLP-1s can vary widely from person to person. Clinical studies show that Tirzepatide can lead to an average weight loss of 15-20% over a year, while Semaglutide usually results in around 15% average weight loss. Factors like starting weight, diet, exercise, and metabolism all play a role. Weight loss typically happens gradually, and significant results aren’t guaranteed for everyone. Pairing GLP-1s with healthy eating and regular exercise can improve outcomes.

Weight loss results with GLP-1s can vary widely from person to person. On average, these medications can lead to 15-20% weight loss over a year, translating to about 1-3 pounds a week for many. Factors like starting weight, diet, exercise, and metabolism all play a role, and results often come gradually. Combining GLP-1s with healthy eating and regular exercise can enhance your results.

Semaglutide mimics the effects of a hormone called glucagon-like peptide-1 (GLP-1) in the body, facilitating the regulation of blood sugar levels by stimulating insulin release, slowing gastric emptying which makes you feel full longer, and reducing appetite.⁴

Tirzepatide mimics two hormones that help regulate blood sugar levels: GLP-1 and GIP. It stimulates insulin release, slows down stomach emptying, and reduces appetite, which can help you feel fuller for longer and support better blood sugar control.⁵

Choosing between Semaglutide and Tirzepatide depends on your goals. Both are effective GLP-1 agonists for weight loss. Semaglutide acts on the GLP-1 receptor, increasing insulin production and enhancing feelings of fullness. In contrast, Tirzepatide activates two receptors—GLP-1 and GIP—potentially making it about twice as effective in clinical studies. If you're aiming for greater weight loss, Tirzepatide may offer an advantage.

Injectable semaglutide is generally more effective because it bypasses the digestive system, leading to better absorption in the bloodstream. Injections typically deliver a higher dose of the medication compared to oral forms, resulting in more significant weight loss in clinical studies. However, individual factors like metabolism and adherence to treatment can influence effectiveness. While injections generally offer better results, some people prefer the convenience of oral medication.

Not at this time. For nausea, we recommend taking 10 to 25 milligrams (mg) of vitamin B6 every 8 hours. Some say it has results similar to Zofran, although side effects can include headaches and fatigue. You may request a prescription of Zofran from your primary care physician.

Not at this time. Stay tuned for additional products we may cover in the future!

1. Human Drug Compounding

2. Compounding and the FDA: Questions and Answers

3. Section 503A of the FDCA

4. Semaglutide | FDA

5. Tirzepatide | MedlinePlus